Krystal Biotech, Inc. to Present at the 30th Annual ROTH Conference

PITTSBURGH, March 05, 2018 (GLOBE NEWSWIRE) -- Krystal Biotech, Inc. (NASDAQ: KRYS), a gene therapy company advancing “off-the-shelf,” treatments for dermatological diseases, today announced that Krish Krishnan, Chief Executive Officer, will present a corporate overview and business update at the ROTH Capital Markets Growth Conference, taking place March 11-13 at the Ritz Carlton hotel in Laguna Niguel, California.

30th Annual ROTH ConferenceDate: Monday, March 12Time: 10:30am Pacific TimeLocation:  Ritz Carlton Hotel, Salon 6Webcast: http://wsw.com/webcast/roth32/krys/

About Krystal BiotechKrystal Biotech, Inc. (NASDAQ: KRYS) is a gene therapy company dedicated to developing and commercializing novel treatments for patients suffering from dermatological diseases. For more information, please visit http://www.krystalbio.com. 

CONTACT Ashley R. Robinson  LifeSci Advisors [email protected] 

Source: Krystal Biotech, Inc.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Latest Crypto News: Bitcoin Rips Past $77K, Cardano Turns Bullish – Is Apeing Whitelist the Next Move for Traders? 
• BNP PARIBAS GROUP: SUDAN LITIGATION STATEMENT FROM BNP PARIBAS
• pixelgrinder Announces Second Full-Length Album “White Mask” for September 25 Release